vs

Side-by-side financial comparison of Arcellx, Inc. (ACLX) and Aterian, Inc. (ATER). Click either name above to swap in a different company.

Aterian, Inc. is the larger business by last-quarter revenue ($15.1M vs $8.1M, roughly 1.9× Arcellx, Inc.). Aterian, Inc. runs the higher net margin — -52.5% vs -766.0%, a 713.5% gap on every dollar of revenue. On growth, Aterian, Inc. posted the faster year-over-year revenue change (-38.5% vs -79.3%). Aterian, Inc. produced more free cash flow last quarter ($-1.0M vs $-63.9M). Over the past eight quarters, Aterian, Inc.'s revenue compounded faster (-13.5% CAGR vs -24.6%).

Arcellx, Inc. is a clinical-stage biotechnology company that develops innovative chimeric antigen receptor T (CAR-T) cell therapies for treating hard-to-treat cancers including hematologic malignancies and solid tumors. Its core pipeline targets unmet oncology medical needs, serving global patient populations and partnering with life sciences stakeholders.

Aterian, Inc. is a technology-enabled consumer products company that leverages artificial intelligence and data analytics to identify market demand, develop, source and distribute a wide portfolio of affordable goods spanning home improvement, wellness, personal care, pet supplies and outdoor recreation. It primarily sells its products through leading global e-commerce platforms, with core markets covering North America and Europe.

ACLX vs ATER — Head-to-Head

Bigger by revenue
ATER
ATER
1.9× larger
ATER
$15.1M
$8.1M
ACLX
Growing faster (revenue YoY)
ATER
ATER
+40.8% gap
ATER
-38.5%
-79.3%
ACLX
Higher net margin
ATER
ATER
713.5% more per $
ATER
-52.5%
-766.0%
ACLX
More free cash flow
ATER
ATER
$62.9M more FCF
ATER
$-1.0M
$-63.9M
ACLX
Faster 2-yr revenue CAGR
ATER
ATER
Annualised
ATER
-13.5%
-24.6%
ACLX

Income Statement — Q1 FY2025 vs Q4 FY2025

Metric
ACLX
ACLX
ATER
ATER
Revenue
$8.1M
$15.1M
Net Profit
$-62.3M
$-7.9M
Gross Margin
56.1%
Operating Margin
-847.6%
-51.1%
Net Margin
-766.0%
-52.5%
Revenue YoY
-79.3%
-38.5%
Net Profit YoY
-765.1%
-512.2%
EPS (diluted)
$-1.13

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ACLX
ACLX
ATER
ATER
Q4 25
$15.1M
Q3 25
$19.0M
Q2 25
$19.5M
Q1 25
$8.1M
$15.4M
Q4 24
$15.3M
$24.6M
Q3 24
$26.0M
$26.2M
Q2 24
$27.4M
$28.0M
Q1 24
$39.3M
$20.2M
Net Profit
ACLX
ACLX
ATER
ATER
Q4 25
$-7.9M
Q3 25
$-2.3M
Q2 25
$-4.9M
Q1 25
$-62.3M
$-3.9M
Q4 24
$-47.1M
$-1.3M
Q3 24
$-25.9M
$-1.8M
Q2 24
$-27.2M
$-3.6M
Q1 24
$-7.2M
$-5.2M
Gross Margin
ACLX
ACLX
ATER
ATER
Q4 25
56.1%
Q3 25
56.1%
Q2 25
54.3%
Q1 25
61.4%
Q4 24
63.4%
Q3 24
60.3%
Q2 24
60.4%
Q1 24
65.1%
Operating Margin
ACLX
ACLX
ATER
ATER
Q4 25
-51.1%
Q3 25
-10.7%
Q2 25
-23.1%
Q1 25
-847.6%
-24.1%
Q4 24
-348.2%
-6.5%
Q3 24
-129.1%
-6.6%
Q2 24
-127.8%
-11.5%
Q1 24
-40.3%
-26.1%
Net Margin
ACLX
ACLX
ATER
ATER
Q4 25
-52.5%
Q3 25
-12.0%
Q2 25
-25.0%
Q1 25
-766.0%
-25.4%
Q4 24
-308.4%
-5.3%
Q3 24
-99.4%
-6.8%
Q2 24
-99.3%
-13.0%
Q1 24
-18.3%
-25.5%
EPS (diluted)
ACLX
ACLX
ATER
ATER
Q4 25
Q3 25
Q2 25
Q1 25
$-1.13
Q4 24
$-0.87
Q3 24
$-0.48
Q2 24
$-0.51
Q1 24
$-0.14

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ACLX
ACLX
ATER
ATER
Cash + ST InvestmentsLiquidity on hand
$543.3M
$4.9M
Total DebtLower is stronger
Stockholders' EquityBook value
$416.9M
$15.2M
Total Assets
$648.1M
$29.6M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ACLX
ACLX
ATER
ATER
Q4 25
$4.9M
Q3 25
$7.6M
Q2 25
$10.5M
Q1 25
$543.3M
$14.3M
Q4 24
$587.4M
$18.0M
Q3 24
$574.3M
$16.1M
Q2 24
$516.7M
$20.3M
Q1 24
$573.9M
$17.5M
Stockholders' Equity
ACLX
ACLX
ATER
ATER
Q4 25
$15.2M
Q3 25
$22.6M
Q2 25
$24.3M
Q1 25
$416.9M
$27.0M
Q4 24
$454.8M
$30.0M
Q3 24
$483.0M
$30.6M
Q2 24
$487.2M
$30.9M
Q1 24
$496.6M
$33.0M
Total Assets
ACLX
ACLX
ATER
ATER
Q4 25
$29.6M
Q3 25
$40.1M
Q2 25
$45.4M
Q1 25
$648.1M
$49.8M
Q4 24
$711.3M
$49.5M
Q3 24
$764.9M
$52.1M
Q2 24
$734.3M
$59.9M
Q1 24
$779.7M
$55.7M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ACLX
ACLX
ATER
ATER
Operating Cash FlowLast quarter
$-63.1M
$-1.0M
Free Cash FlowOCF − Capex
$-63.9M
$-1.0M
FCF MarginFCF / Revenue
-786.4%
-6.9%
Capex IntensityCapex / Revenue
9.6%
0.0%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-122.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ACLX
ACLX
ATER
ATER
Q4 25
$-1.0M
Q3 25
$-1.6M
Q2 25
$-4.4M
Q1 25
$-63.1M
$-3.9M
Q4 24
$-46.0M
$-9.0K
Q3 24
$30.7M
$-722.0K
Q2 24
$-36.2M
$2.9M
Q1 24
$-31.9M
$-6.0K
Free Cash Flow
ACLX
ACLX
ATER
ATER
Q4 25
$-1.0M
Q3 25
$-1.6M
Q2 25
$-4.4M
Q1 25
$-63.9M
Q4 24
$-47.5M
Q3 24
$28.4M
Q2 24
$-39.5M
$2.9M
Q1 24
$-38.3M
$-42.0K
FCF Margin
ACLX
ACLX
ATER
ATER
Q4 25
-6.9%
Q3 25
-8.4%
Q2 25
-22.7%
Q1 25
-786.4%
Q4 24
-311.3%
Q3 24
109.2%
Q2 24
-144.1%
10.3%
Q1 24
-97.7%
-0.2%
Capex Intensity
ACLX
ACLX
ATER
ATER
Q4 25
0.0%
Q3 25
0.2%
Q2 25
0.0%
Q1 25
9.6%
0.0%
Q4 24
9.8%
0.0%
Q3 24
8.8%
0.0%
Q2 24
11.7%
0.0%
Q1 24
16.4%
0.2%

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ACLX
ACLX

Segment breakdown not available.

ATER
ATER

Sales Channel Directly To Consumer$13.1M87%
Heating Cooling And Air Quality$2.1M14%

Related Comparisons